Case number 2016-2550
Forest Laboratories Inc. v. Teva Pharmaceuticals USA Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | FOREST LABORATORIES INC. v. TEVA PHARMACEUTICALS USA INC. [OPINION] [nonprecedential] (0) |
| Feb 20, 2018 | 77 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [499239] [16-2550, 16-2553] [SJ] [Entered: 02/20/2018 09:49 AM] (1) |
| Feb 12, 2018 | 76 | ORDER filed denying [74] petition for panel rehearing filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and Adamas Pharma, LLC; denying [74] petition for en banc rehearing filed by Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and Adamas Pharma, LLC. By: En Banc (Per Curiam). Service as of this date by Clerk of Court. [497001] [SJ] [Entered: 02/12/2018 11:19 AM] (2) |
| Jan 11, 2018 | 75 | 18 paper copies of the petition for panel rehearing [74], petition for en banc rehearing [74] received from Appellants Adamas Pharma, LLC, Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. [489626] [SJ] [Entered: 01/16/2018 10:27 AM] (0) |
| Jan 10, 2018 | 74 | Petition for panel rehearing, for en banc rehearing filed by Appellants Adamas Pharma, LLC, Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 01/10/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 01/12/2018 [488602] [George Pappas] [Entered: 01/10/2018 11:00 AM] (37) |
| Dec 11, 2017 | 73 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Nonprecedential Opinion). (For the Court: Lourie,Circuit Judge; Reyna,Circuit Judge and Taranto,Circuit Judge). [481466] [16-2550, 16-2553] [SJ] [Entered: 12/11/2017 09:21 AM] (23) |
| Nov 14, 2017 | 72 | Letter from Appellee Teva Pharmaceuticals USA Inc Status of U.S. Patent No. 5,061,703. Service: 11/14/2017 by email. [475260] [Mark Schuman] [Entered: 11/14/2017 11:30 AM] (2) |
| Nov 9, 2017 | 71 | Submitted after ORAL ARGUMENT by George Frank Pappas for Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and Adamas Pharma, LLC and Mark David Schuman for Teva Pharmaceuticals USA Inc. Panel: Judge: Lourie , Judge: Reyna , Judge: Taranto. [474221] [JAB] [Entered: 11/09/2017 10:31 AM] (0) |
| Oct 16, 2017 | 70 | Response to oral argument order from the Appellants Adamas Pharma, LLC, Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. designating George F. Pappas as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [468058] [David Denuyl] [Entered: 10/16/2017 01:19 PM] (0) |
| Oct 16, 2017 | 69 | Response to oral argument order from the Appellee Teva Pharmaceuticals USA Inc. designating Mark D. Schuman as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [468015] [Mark Schuman] [Entered: 10/16/2017 12:22 PM] (0) |
| Sep 21, 2017 | 68 | NOTICE OF CALENDARING. Panel: 1711K. Case scheduled Nov 09, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 10/16/2017. Arguing counsel is required to check-in at the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [462691] [JAB] [Entered: 09/21/2017 12:34 PM] (0) |
| Jul 18, 2017 | 67 | Notice from Appellee Teva Pharmaceuticals USA Inc regarding conflicts with oral argument (October 2-6, 2017). Service: 07/18/2017 by email. [447309] [Mark Schuman] [Entered: 07/18/2017 11:04 AM] (2) |
| Jun 28, 2017 | 66 | ORDER filed. The motion [65] is granted. The revised official caption is reflected in the order. Service: 06/28/2017 by clerk. [442862] [LMS] [Entered: 06/28/2017 02:21 PM] (2) |
| Jun 23, 2017 | 65 | MOTION of Appellant Adamas Pharmaceuticals Inc. to substitute party. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/23/2017 by email. [441839] [Jeffrey Elikan] [Entered: 06/23/2017 04:20 PM] (12) |
| Apr 3, 2017 | 64 | Notice from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. regarding conflicts with oral argument (Appellants-Plaintiffs' counsel has conflicts on June 5-9, July 10-14, and September 5-19, 2017.). Service: 04/03/2017 by email. [421102] [George Pappas] [Entered: 04/03/2017 08:56 PM] (2) |
| Apr 3, 2017 | 63 | Notice from Appellee Teva Pharmaceuticals USA Inc regarding conflicts with oral argument (May 1-5 & 8, August 7-11, April 20, and June 5-9, 2017). Service: 04/03/2017 by email. [421015] [Mark Schuman] [Entered: 04/03/2017 03:01 PM] (3) |
| Mar 30, 2017 | 62 | Notice from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. regarding conflicts with oral argument (Counsel for Forest Laboratories and Adamas Pharmaceuticals has conflicts on June 5-9, July 10-14, and September 11-15.). Service: 03/30/2017 by email. [420461] [George Pappas] [Entered: 03/30/2017 04:29 PM] (2) |
| Mar 30, 2017 | 61 | 6 paper copies of the Joint Appendix [59] received from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc. and Appellee Teva Pharmaceuticals USA Inc. [420367] [KW] [Entered: 03/30/2017 03:19 PM] (0) |
| Mar 27, 2017 | 60 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/03/2017. [419137] [JB] [Entered: 03/27/2017 01:58 PM] (0) |
| Mar 24, 2017 | 59 | APPENDIX FILED for Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc. and Teva Pharmaceuticals USA Inc [57]. Number of Pages: 635. Service: 03/24/2017 by email. The paper copies of the brief should be received by the court on or before 04/03/2017. [419135] [JB] [Entered: 03/27/2017 01:56 PM] (636) |
| Mar 24, 2017 | 58 | 6 paper copies of the Reply Brief [53] received from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. [419029] [KW] [Entered: 03/27/2017 11:12 AM] (0) |
| Mar 24, 2017 | 57 | TENDERED from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc. and Appellee Teva Pharmaceuticals USA Inc. Title: JOINT APPENDIX. Service: 03/24/2017 by email. [418883] [Jeffrey Elikan] [Entered: 03/24/2017 04:33 PM] (636) |
| Mar 24, 2017 | 56 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd., Forest Laboratories Inc. and Appellee Teva Pharmaceuticals USA Inc. Service: 03/24/2017 by email. [418881] [Jeffrey Elikan] [Entered: 03/24/2017 04:29 PM] (3) |
| Mar 24, 2017 | 55 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 03/24/2017 by email. [418879] [Jeffrey Elikan] [Entered: 03/24/2017 04:28 PM] (3) |
| Mar 24, 2017 | 54 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Teva Pharmaceuticals USA Inc. Service: 03/24/2017 by email. [418862] [Mark Schuman] [Entered: 03/24/2017 04:07 PM] (3) |
| Mar 17, 2017 | 53 | REPLY BRIEF FILED for Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. [52]. Number of Pages: 29. Service: 03/17/2017 by email. The paper copies of the brief should be received by the court on or before 03/27/2017. Appendix is due 03/24/2017. [416990] [JB] [Entered: 03/20/2017 01:10 PM] (40) |
| Mar 17, 2017 | 52 | TENDERED from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Title: REPLY BRIEF. Service: 03/17/2017 by email. [416735] [Jeffrey Elikan] [Entered: 03/17/2017 04:39 PM] (40) |
| Mar 8, 2017 | 51 | **TEXT ONLY** ORDER granting motion to withdraw attorney Christopher A. Pinahs [50] filed by Appellee Teva Pharmaceuticals USA Inc. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [413346] [JB] [Entered: 03/08/2017 11:33 AM] (0) |
| Mar 7, 2017 | 50 | MOTION of Appellee Teva Pharmaceuticals USA Inc to withdraw counsel Christopher A. Pinahs. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/07/2017 by email. [413101] [Mark Schuman] [Entered: 03/07/2017 03:02 PM] (5) |
| Feb 9, 2017 | 48 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [47] filed by Appellants Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and Adamas Pharmaceuticals Inc. Reply brief is due 03/17/2017.Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [405860] [JB] [Entered: 02/09/2017 09:50 AM] (0) |
| Feb 8, 2017 | 49 | 6 paper copies of the Response Brief [46] received from Appellee Teva Pharmaceuticals USA Inc. [405981] [KW] [Entered: 02/09/2017 01:26 PM] (0) |
| Feb 7, 2017 | 47 | MOTION of Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. to extend the time to 03/17/2017 at 11:59 pm to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/07/2017 by email. [405303] [Jeffrey Elikan] [Entered: 02/07/2017 02:02 PM] (11) |
| Feb 2, 2017 | 46 | BRIEF FILED for Appellee Teva Pharmaceuticals USA Inc [45]. Number of Pages: 39. Service: 02/01/2017 by email. The paper copies of the brief should be received by the court on or before 02/09/2017. Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. reply brief is due 02/15/2017. [404228] [JB] [Entered: 02/02/2017 02:23 PM] (50) |
| Feb 1, 2017 | 45 | TENDERED from Appellee Teva Pharmaceuticals USA Inc. Title: OPENING BRIEF. Service: 02/01/2017 by email. [403968] [Mark Schuman] [Entered: 02/01/2017 04:32 PM] (50) |
| Jan 6, 2017 | 44 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [43] filed by Appellee Teva Pharmaceuticals USA Inc. Brief due 02/01/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [396841] [JB] [Entered: 01/06/2017 03:22 PM] (0) |
| Jan 6, 2017 | 43 | MOTION of Appellee Teva Pharmaceuticals USA Inc to extend the time to 02/01/2017 to file Teva's principal brief and Teva does not oppose a reciprocal 14-day extension for Forest's reply brief. to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/06/2017 by email. [396695] [Mark Schuman] [Entered: 01/06/2017 11:27 AM] (6) |
| Dec 20, 2016 | 42 | 6 paper copies of the Corrected Opening Brief [41] received from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. [393187] [KW] [Entered: 12/21/2016 01:44 PM] (0) |
| Dec 15, 2016 | 40 | TENDERED from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Title: CORRECTED OPENING BRIEF. Service: 12/15/2016 by email. [391611] [Jeffrey Elikan] [Entered: 12/15/2016 05:46 PM] (122) |
| Dec 15, 2016 | 41 | CORRECTED BRIEF FILED for Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. [40]. Number of Pages: 43. Service: 12/15/2016 by email. The paper copies of the brief should be received by the court on or before 12/27/2016. [392162] [JB] [Entered: 12/19/2016 10:58 AM] (122) |
| Dec 9, 2016 | 39 | NOTICE OF REJECTION: The brief of Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc., Opening Brief [38], is not in compliance with the rules of this court and is therefore rejected for filing. Corrected Brief due 12/23/2016. Appellee Teva Pharmaceuticals USA Inc brief is due 01/18/2017. Service as of this date by Clerk of Court. [389678] [JB] [Entered: 12/09/2016 09:30 AM] (2) |
| Dec 8, 2016 | 38 | TENDERED from Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Title: OPENING BRIEF. Service: 12/08/2016 by email. [389619] This brief has been rejected. See Doc No [39] [Jeffrey Elikan] [Entered: 12/08/2016 04:29 PM] (0) |
| Dec 6, 2016 | 37 | Entry of appearance for Bradley K. Ervin as of counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 12/06/2016 by email. [388804] [Bradley Ervin] [Entered: 12/06/2016 07:30 PM] (2) |
| Dec 6, 2016 | 36 | Entry of appearance for David S. Denuyl as of counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 12/06/2016 by email. [388803] [David Denuyl] [Entered: 12/06/2016 07:27 PM] (2) |
| Dec 6, 2016 | 35 | Entry of appearance for Eric R. Sonnenschein as of counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 12/06/2016 by email. [388802] [Eric Sonnenschein] [Entered: 12/06/2016 07:23 PM] (2) |
| Dec 6, 2016 | 34 | Entry of appearance for George F. Pappas as of counsel for Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 12/06/2016 by email. [388800] [George Pappas] [Entered: 12/06/2016 07:16 PM] (2) |
| Dec 6, 2016 | 33 | Entry of appearance for Jeremy D. Cobb as of counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 12/06/2016 by email. [388799] [Jeremy Cobb] [Entered: 12/06/2016 07:13 PM] (2) |
| Dec 6, 2016 | 32 | Entry of appearance for Jeffrey B. Elikan as of counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 12/06/2016 by email. [388797] [Jeffrey Elikan] [Entered: 12/06/2016 06:56 PM] (2) |
| Oct 21, 2016 | 31 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [376555] [JB] [Entered: 10/21/2016 12:58 PM] (0) |
| Sep 12, 2016 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [29] filed by Appellants Forest Laboratories Inc., Forest Laboratories Holdings Ltd. and Adamas Pharmaceuticals Inc. Brief due 12/08/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [365870] [JB] [Entered: 09/12/2016 03:17 PM] (0) |
| Sep 9, 2016 | 29 | MOTION of Appellants Adamas Pharmaceuticals Inc., Forest Laboratories Holdings Ltd. and Forest Laboratories Inc. to extend the time to 12/08/2016 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 09/22/2016 [Consent: unopposed]. Service: 09/09/2016 by email. [365563] [Jeffrey Elikan] [Entered: 09/09/2016 02:24 PM] (15) |
| Sep 8, 2016 | 28 | Corrected Docketing Statement for the Appellee Teva Pharmaceuticals USA Inc. Service: 09/08/2016 by email. [365171] [Mark Schuman] [Entered: 09/08/2016 12:23 PM] (4) |
| Sep 8, 2016 | 27 | Corrected Certificate of Interest for the Appellee Teva Pharmaceuticals USA Inc. Service: 09/08/2016 by email. [365168] [Mark Schuman] [Entered: 09/08/2016 12:22 PM] (3) |
| Sep 8, 2016 | 26 | Corrected Entry of appearance for Christopher A. Pinahs as of counsel for Appellee Teva Pharmaceuticals USA Inc. Service: 09/08/2016 by email. [365164] [Mark Schuman] [Entered: 09/08/2016 12:19 PM] (2) |
| Sep 8, 2016 | 25 | Corrected Entry of appearance for Jennell C. Bilek as of counsel for Appellee Teva Pharmaceuticals USA Inc. Service: 09/08/2016 by email. [365160] [Mark Schuman] [Entered: 09/08/2016 12:15 PM] (2) |
| Sep 8, 2016 | 24 | Corrected Entry of appearance for Jeffer Ali as of counsel for Appellee Teva Pharmaceuticals USA Inc. Service: 09/08/2016 by email. [365155] [Mark Schuman] [Entered: 09/08/2016 12:14 PM] (2) |
| Sep 8, 2016 | 23 | Corrected Entry of appearance for Mark D. Schuman as principal counsel for Appellee Teva Pharmaceuticals USA Inc. Service: 09/08/2016 by email. [365151] [Mark Schuman] [Entered: 09/08/2016 12:12 PM] (2) |
| Sep 8, 2016 | 22 | Certificate of Interest for the Appellant Adamas Pharmaceuticals Inc.. Service: 09/08/2016 by email. [365105] [Peter Armenio] [Entered: 09/08/2016 10:39 AM] (5) |
| Sep 8, 2016 | 21 | Corrected Certificate of Interest for the Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/08/2016 by email. [365059] [Jeffrey Elikan] [Entered: 09/08/2016 09:32 AM] (5) |
| Sep 8, 2016 | 20 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: ADAMAS PHARMACEUTICALS INC's certificate of interest Docket Nos. [16], [15], ERROR: The COI and its attachment were filed using two separate ECF events; the COI is not text-searchable. CORRECTION: The COI and its attachment should be filed in a single ECF event; please re-enter the COI and its attachment using a single "Certificate of Interest filed" event. The COI must be in text-searchable format. [365053] [AT] [Entered: 09/08/2016 09:27 AM] (0) |
| Sep 8, 2016 | 19 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: FOREST LABORATORIES INC's certificate of interest Docket Nos. [13], [10], ERROR: The COI and its attachment were filed using two separate ECF events. CORRECTION: The COI and its attachment should be filed in a single ECF event; please re-enter the COI and its attachment using a single "Certificate of Interest filed" event. [365050] [AT] [Entered: 09/08/2016 09:24 AM] (0) |
| Sep 7, 2016 | 18 | Entry of appearance for Peter J. Armenio as of counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [365011] [Peter Armenio] [Entered: 09/07/2016 11:33 PM] (2) |
| Sep 7, 2016 | 17 | Entry of appearance for Peter J. Armenio as principal counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 09/07/2016 by email. [365008] [Peter Armenio] [Entered: 09/07/2016 11:29 PM] (2) |
| Sep 7, 2016 | 16 | Certificate of Interest for the Appellant Adamas Pharmaceuticals Inc.. Service: 09/07/2016 by email. [365004] [Peter Armenio] [Entered: 09/07/2016 10:27 PM] (2) |
| Sep 7, 2016 | 15 | Certificate of Interest for the Appellant Adamas Pharmaceuticals Inc.. Service: 09/07/2016 by email. [365003] [Peter Armenio] [Entered: 09/07/2016 10:24 PM] (4) |
| Sep 7, 2016 | 14 | Docketing Statement for the Appellant Adamas Pharmaceuticals Inc.. Service: 09/07/2016 by email. [365002] [Peter Armenio] [Entered: 09/07/2016 10:08 PM] (3) |
| Sep 7, 2016 | 13 | Certificate of Interest for the Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364998] [Jeffrey Elikan] [Entered: 09/07/2016 08:52 PM] (3) |
| Sep 7, 2016 | 12 | Entry of appearance for Bradley K. Ervin as of counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364995] [Bradley Ervin] [Entered: 09/07/2016 08:40 PM] (2) |
| Sep 7, 2016 | 11 | Docketing Statement for the Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364994] [Jeffrey Elikan] [Entered: 09/07/2016 08:34 PM] (3) |
| Sep 7, 2016 | 10 | Certificate of Interest for the Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364993] [Jeffrey Elikan] [Entered: 09/07/2016 08:30 PM] (2) |
| Sep 7, 2016 | 9 | Entry of appearance for David S. Denuyl as of counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364992] [David Denuyl] [Entered: 09/07/2016 08:24 PM] (2) |
| Sep 7, 2016 | 8 | Entry of appearance for Eric R. Sonnenschein as of counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364991] [Eric Sonnenschein] [Entered: 09/07/2016 08:19 PM] (2) |
| Sep 7, 2016 | 7 | Entry of appearance for Jeremy D. Cobb as of counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364990] [Jeremy Cobb] [Entered: 09/07/2016 08:14 PM] (2) |
| Sep 7, 2016 | 6 | Entry of appearance for Jeffrey B. Elikan as principal counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364988] [Jeffrey Elikan] [Entered: 09/07/2016 08:06 PM] (2) |
| Sep 7, 2016 | 5 | Entry of appearance for Peter J. Armenio as principal counsel for Appellant Adamas Pharmaceuticals Inc.. Service: 09/07/2016 by email. [364945] [Peter Armenio] [Entered: 09/07/2016 05:30 PM] (1) |
| Sep 7, 2016 | 4 | Entry of appearance for Peter J. Armenio as of counsel for Appellants Forest Laboratories Holdings Ltd. and Forest Laboratories Inc.. Service: 09/07/2016 by email. [364942] [Peter Armenio] [Entered: 09/07/2016 05:28 PM] (1) |
| Sep 1, 2016 | 3 | Corrected Notice of Docketing issued [to correct the originating case number]. Service as of this date by Clerk of Court. [363616] [IW] [Entered: 09/01/2016 10:26 AM] (1) |
| Aug 24, 2016 | 2 | Note to file: The following cases are associated:16-2550 Lead with 16-2553 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [361574] [JB] [Entered: 08/24/2016 12:50 PM] (0) |
| Aug 24, 2016 | 1 | Appeal docketed. Received: 08/24/2016. [361564]Entry of Appearance due 09/07/2016. Certificate of Interest is due on 09/07/2016. Docketing Statement due 09/07/2016. Appellant/Petitioner's brief is due 10/24/2016. [JB] [Entered: 08/24/2016 12:34 PM] (75) |
